Amanda Galgay
Public Communications Contact chez TANGO THERAPEUTICS, INC.
Profil
Amanda Brown Galgay is currently the Vice President-Communications at Exscientia AI Ltd.
and the Senior Vice President-Corporate Communications at Tango Therapeutics, Inc. Previously, she held the position of Vice President-Corporate & Investor Communications at Pear Therapeutics (US), Inc. and Vice President-Corporate Affairs at Ohana Biosciences, Inc. She also worked as the Vice President-Communications at Exscientia Plc from 2021 to 2022.
Ms. Galgay completed her undergraduate degree at the University of Missouri Extension.
Postes actifs de Amanda Galgay
| Sociétés | Poste | Début |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Public Communications Contact | - |
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Public Communications Contact | - |
Anciens postes connus de Amanda Galgay
| Sociétés | Poste | Fin |
|---|---|---|
| EXSCIENTIA PLC | Public Communications Contact | 31/12/2022 |
Pear Therapeutics (US), Inc.
 Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Investor Relations Contact | - |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Amanda Galgay
| University of Missouri Extension | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| TANGO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Ohana Biosciences, Inc.
Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Commercial Services |
Pear Therapeutics (US), Inc.
Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Technology Services |